ScreenerHero
TN8Thermo Fisher Scientific Inc.
XETRA · DE · Healthcare · Diagnostics & Research · thermofisher.com
541.20EUR+2.66%Mkt Cap: 217.51B $P/E: 33.76

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Scien…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap217.51B $
Enterprise Value245.17B $
Revenue (TTM)50.37B $
Gross Profit19.82B $
Net Income (TTM)7.29B $
Revenue/Share134.67 USD
Last Price541.20 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees125.0K
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINUS8835561023
Valuation
P/E (Trailing)33.76
P/E (Forward)—
PEG1.93
EV/EBITDA19.21
EV/Revenue4.87
P/S4.03
P/B4.13
EPS (TTM)16.04
EPS (Forward)—
52W Range
505.60100% of range541.20
52W High541.20 EUR
52W Low505.60 EUR
Profitability
Gross Margin40.93%
Oper. Margin18.75%
EBITDA Margin25.34%
Profit Margin15.05%
ROE12.55%
ROA6.08%
Growth
Revenue Growth10.50%
Earnings Growth9.40%
Cash Flow & Leverage
Operating CF8.50B $
CapEx (TTM)1.66B $
FCF Margin13.46%
FCF Yield3.12%
Net Debt41.83B $
Net Debt/EBITDA3.28
Balance Sheet
Debt/Equity0.74
Current Ratio1.55
Quick Ratio1.01
Book Value/Sh122.44 EUR
Cash/Share10.99 EUR
Dividends
Fwd Div Rate1.650 EUR
Trail. Div Rate1.800 EUR
Div. Yield0.32%
5Y Avg Yield0.25%
Payout Ratio9.69%
Ex-Div DateSep 15, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.369.75M
Float368.82M
Insiders0.13%
Institutions98.81%
Technical
SMA 50462.23 (+17.1%)
SMA 200456.37 (+18.6%)
Beta0.85
S&P 52W Chg20.80%
Avg Vol (30d)231
Avg Vol (10d)194
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—